News – Page 502 – Endpoints News

CytomX halts lead program and will seek a partner as breast cancer drug disappoints

3 years ago

‘Unconscious biases’ and lack of trust lead to gaps in routine healthcare for LGBTQ+ community — study

3 years ago

Lotte Group turns to Merck KGaA’s US unit for leg up at new Syracuse biologics plant

3 years ago

Schumer moves forward on Medicare drug price negotiations with Manchin's support — reports

3 years ago

Mylan Pharmaceuticals faces another recall on insulin injection pens

3 years ago

GSK's consumer health spinoff Haleon preps launch with $12B+ in debt

3 years ago

As new monkeypox cases spike globally, Labcorp rolls out first national lab test

3 years ago

Pulmonologist and frequent NBC guest in consideration for senior role at FDA — report

3 years ago

In wake of IP claims targeting its megablockbuster, BioNTech mulls a few next steps of its own

3 years ago

Heart inflammation emerges in a Sarepta Duchenne patient, clouding an otherwise positive readout

3 years ago

Two months after CRL, FDA accepts Coherus, Junshi's resubmission for PD-1 studied in China

3 years ago

Applied Molecular Transport’s shot at beating Humira in UC fails in mid-stage study, sinking shares nearly 30%

3 years ago

Catalent’s new CEO takes the reins as the drug manufacturer adjusts its operational structure

3 years ago

Urovant hops across the pond, out-licensing overactive bladder drug to Pierre Fabre for $75M

3 years ago

Reorg coming for little biotech as it shutters PhII radioimmunotherapy trial on underwhelming data

3 years ago

The 2022 Endpoints 11 is coming. Do you know a biotech that should be on the list?

3 years ago

Bill Haney's latest startup scores deal from Sanofi, its newest Big Pharma partner, with $54M upfront

3 years ago

Boehringer Ingelheim, Evotec band with diagnostics player to tackle 'superbugs' through joint venture

3 years ago

Pfizer lines up access to 'doggybone DNA' in manufacturing of mRNA vaccines, gene therapies and more

3 years ago

Alzheimer's quick OK, take two: FDA offers Biogen, Eisai a shortcut to a possible lecanemab approval

3 years ago

Texas drug manufacturer smacked with FDA warning letter over multiple violations

3 years ago

OIG report accuses FDA of not following policies for foreign drug inspections

3 years ago

Biogen leans into digital therapeutics for multiple sclerosis, teams with Happify Health

3 years ago

Sanofi jumpstarts effort to supply 30 'essential' drugs to lower-income countries

3 years ago

First page Previous page 499 500 501502503 504 505 Next page Last page